• CLSI EP25-A

CLSI EP25-A

Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline, EP25A

Clinical and Laboratory Standards Institute, 09/01/2009

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/09/2009

Pages:56

File Size:1 file , 1.5 MB

Note:This product is unavailable in Russia, Belarus

Clinical and Laboratory Standards Institute document EP25-A--Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline provides guidance and regression-based procedures for establishing stability-related claims of in vitro diagnostic (IVD) reagents such as reagent kits, calibrators, control products, and sample diluents. This guideline was written primarily for manufacturers and regulatory agencies, but will also be of interest to clinical laboratories. It provides information on the design, implementation, data analysis, and documentation needs for studies to establish and verify shelf life and in-use life of IVD reagents. Additional topics address assessment of product transport conditions on stability and accelerated stability testing.

More CLSI standard pdf

CLSI MM19-A

CLSI MM19-A

Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AE

$90.00 $180.00

CLSI M43-A

CLSI M43-A

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE

$90.00 $180.00

CLSI EP23-A (R2018)

CLSI EP23-A (R2018)

Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE

$90.00 $180.00

CLSI VET05-R (R2018)

CLSI VET05-R (R2018)

Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE

$90.00 $180.00